I shed 6st in 9 months on fat jabs – the rule you need to follow to not put weight back on & it works when eating out
WEIGHT UP! I shed 6st in 9 months on fat jabs – the rule you need to follow to not put weight back on & it works when eating out
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
A WOMAN who shed a whopping 6st in just nine months has shared the secret behind not pilling back all the pounds when eating out.
Lucy Davies kickstarted her weight loss journey with the popular fat jab almost a year ago and has since managed to shed a staggering 6 stone.
Sign up for Scottish Sun
newsletter
Sign up
3
he blonde beauty has also been documenting the process and her experience with Mounjaro on TikTok
Credit: tiktok/@insightfullucy
3
She recently revealed her tip for not putting all the weight back on
Credit: @insightfullucy
3
Mounjaro is typically used to treat type 2 diabetes
Credit: Getty
The blonde beauty has also been documenting the process and her experience with Mounjaro on TikTok - where she recently revealed she still enjoys eating out every now and then.
Mounjaro is regarded by some as the King Kong of weight loss jabs.
Sun GP Dr Zoe Williams acknowledged that Mounjaro, which has been rolled out on the NHS, can save the lives of people with 'life-threatening levels of obesity.'
But despite this, the NHS warned: 'Never take an anti-obesity medicine if it has not been prescribed to you.
"These types of medicines may not be safe for you and can cause serious side effects.'
About half a million Brits use weight loss drugs - and the number is expected to double in the next year.
Mounjaro works by suppressing your appetite, making people feel fuller for longer.
The injections are licensed for patients with type 2 diabetes and to assist those who are clinically obese (with a Body Mass Index of 30 or over).
One jab is administered each week but the duration is dependent on someone's weight.
Lucy's results were no doubt impressive - and despite looking incredible, she still enjoys the foods she loves, and it's all thanks to one key tip.
Towie star Saffron Lempriere reveals how she lost 12 pounds in 4 weeks - without fat jabs
The stunner, who posts under the username @insightfullucy, explained that she's ''always loved eating out''.
But while many of may stuff our faces - which is also needed from time to time - Lucy has maintained her enviable figure with ensuring she doesn't go overboard.
''I just make sure I stick to a calorie deficit,'' she told her 34k followers in a recent video.
Everything you need to know about fat jabs
Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases.
Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK.
Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market.
Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year.
How do they work?
The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight.
They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists.
They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high.
Can I get them?
NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics.
Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure.
GPs generally do not prescribe the drugs for weight loss.
Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk.
Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health.
Are there any risks?
Yes – side effects are common but most are relatively mild.
Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea.
Dr Sarah Jarvis, GP and clinical consultant at patient.info, said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.'
Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia.
Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health.
Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
A calorie deficit is often touted as the key to weight loss - it's when you consume fewer calories than you burn in a day.
Calories are the energy you get from food, fuelling everything from breathing to exercise.
When you're in a calorie deficit, your body draws on stored energy (primarily fat) to make up the difference, which can lead to weight loss over time.
To reach a calorie deficit, you need to either eat fewer calories, increase physical activity or do a combination of both.
For example, if your calories are 2,000 per day, reducing to 1,500 calories or boosting physical activity by 500 calories would create a deficit.
However, it's worth emphasising that creating a calorie deficit isn't a one-size-fits-all approach.
Factors like age, how active you are, health conditions and metabolic rate - the speed at which your body burns calories at rest - can all affect your personal calorie needs.
Thanks to being mindful, Lucy's managed to lose weight - whilst still consuming a variety of foods, including sweet potato fries which typically tend to be more fatty.
However, that doesn't mean Lucy eats like this all the time - there have also been plenty of occasions when the foodie has opted for healthier, more veggie-heavy options to keep the calories lower.
''You can still enjoy eating out on Mounjaro,'' Lucy wrote in the caption.
What are the other side effects of weight loss jabs?
Like any medication, weight loss jabs can have side effects.
Common side effects of injections such as Ozempic include:
Nausea: This is the most commonly reported side effect, especially when first starting the medication. It often decreases over time as your body adjusts.
Vomiting: Can occur, often in conjunction with nausea.
Diarrhea: Some people experience gastrointestinal upset.
Constipation: Some individuals may also experience constipation.
Stomach pain or discomfort: Some people may experience abdominal pain or discomfort.
Reduced appetite: This is often a desired effect for people using Ozempic for weight loss.
Indigestion: Can cause a feeling of bloating or discomfort after eating.
Serious side effects can also include:
Pancreatitis: In rare cases, Ozempic may increase the risk of inflammation of the pancreas, known as pancreatitis, which can cause severe stomach pain, nausea, and vomiting.
Kidney problems: There have been reports of kidney issues, including kidney failure, though this is uncommon.
Thyroid tumors: There's a potential increased risk of thyroid cancer, although this risk is based on animal studies. It is not confirmed in humans, but people with a history of thyroid cancer should avoid Ozempic.
Vision problems: Rapid changes in blood sugar levels may affect vision, and some people have reported blurry vision when taking Ozempic.
Hypoglycemia (low blood sugar): Especially if used with other medications like sulfonylureas or insulin.
The reality of Mounjaro
Although many have boasted about weight loss success since using Mounjaro, last year it was revealed that Scots nurse Susan McGowan, 58, died after taking low-dose injections of Mounjaro over a fortnight.
A probe also found that nearly 400 people have gone to hospital after taking weight loss drugs.
The common side effects include nausea, vomiting and diarrhoea, which can lead to severe dehydration.
And if that wasn't bad enough, doctors say they have also seen 'life-threatening complications', including seizures, bowel obstruction and inflammation of the pancreas.
Model Lottie Moss, 27, even said she had a seizure after taking high doses of Ozempic.
The makers of Mounjaro, Lilly UK, said patient safety is its 'top priority'.
Lilly UK stressed: 'Regulatory agencies conduct extensive independent assessments of the benefits and risks of every new medicine and Lilly is committed to continually monitoring, evaluating, and reporting safety data.
'If anyone is experiencing side effects when taking any Lilly medicine, they should talk to their doctor or other healthcare professional.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
4 minutes ago
- The Independent
Failings identified in care of boy who died after he was sent home from A&E
The mother of a five-year-old boy who died after he was sent home from A&E has said she hears her son every night saying 'Mummy, I can't breathe', as a report concluded she was not listened to by health professionals. Yusuf Mahmud Nazir died at Sheffield Children's Hospital on November 23 2022, eight days after he was seen at Rotherham Hospital and sent home with antibiotics. A fresh report into Yusuf's care was published on Thursday with a range of recommendations for the NHS, but his family said there are still many unanswered questions and have demanded an inquest into his death. The report said in its conclusions: 'Our primary finding is that the parental concerns, particularly the mother's instinct that her child was unwell, were repeatedly not addressed across services. 'A reliance on clinical metrics over caregiver insight caused distress for the family. 'This led to a lack of shared decision-making and there was limited evidence of collaborative discussions with Yusuf's family around clinical decisions, leading to a sense of exclusion and reduced trust in care plans.' Speaking at a press conference in Rotherham, Yusuf's mother, Soniya Ahmed, said: 'For the medical staff there are lessons to be learnt from this tragedy, but for us, our life, Yusuf has been taken away from us in the most horrific way. 'Every night when I close my eyes I hear Yusuf's helpless voice in my ears saying, 'Mummy, I can't breathe, I can't breathe, I really can't'. 'And the image of him being handed over to me after his life ended, as though someone has torn my heart out and placed it in my hands.' Ms Ahmed choked back tears as she said: 'Along with these failings, there is still uncertainty on his cause of death. 'Yusuf deserved better. Every child does. I will never stop speaking his name. I will never stop fighting for him. I fight for every child failed by the NHS. 'We demand accountability, we demand change. 'We want to know how our son has died and who is responsible, and the only way we will get these answers is with an inquest. The family demand an inquest.' Yusuf's uncle Zaheer Ahmed has always said they were told 'there are no beds and not enough doctors' in the emergency department, and that Yusuf should have been admitted and given intravenous antibiotics in Rotherham. Yusuf, who had asthma, was taken to a GP with a sore throat and feeling unwell on November 15. He was prescribed antibiotics by an advanced nurse practitioner. Later that evening, his parents took him to Rotherham Hospital urgent and emergency care centre (UECC) where he was seen in the early hours of the morning after a six-hour wait. He was discharged with a diagnosis of severe tonsillitis and an extended prescription of antibiotics. Two days later Yusuf was given further antibiotics by his GP for a possible chest infection, but his family became so concerned they called an ambulance and insisted the paramedics take him to Sheffield Children's Hospital rather than Rotherham. Yusuf was admitted to the intensive care unit on November 21 but developed multi-organ failure and suffered several cardiac arrests which he did not survive. A report into his case in October 2023, produced by independent consultants and published by NHS South Yorkshire, found his care was appropriate and 'an admission was not clinically required', but this was rejected by his family. The fresh report by Peter Carter, former general secretary of the Royal College of Nursing, said it was agreed that Yusuf had pneumonia and sepsis, which led to respiratory failure and his death, but 'no causative agent' could be found. It said: 'It is impossible to make a statement on whether (intravenous) antibiotics or earlier detection would have prevented Yusuf's death. 'We understand that this is not the information that the family obtained initially and appreciate how this difference of professional opinion has led to confusion and emotional distress for the family.' The report said Yusuf had 23 separate healthcare contacts across four organisations 'with no single, co-ordinated record or oversight, contributing to fragmented and disjointed care'. The family said they were most surprised by the report's findings in relation to Sheffield Children's Hospital, including that it used an outdated cannula method which deprived Yusuf of drugs he needed. But the report also said it asked experts to assess whether there was 'any clinical evidence to suggest that Yusuf's earlier admission to (Rotherham Hospital) for IV antibiotics, would have possibly prevented Yusuf's death', and the reply was: 'I do not believe it would have done.' Mr Ahmed said on Thursday: 'Despite the report's findings, we still believe that if Yusuf was admitted to Rotherham General Hospital and has received IV antibiotics, that he would still be here today.' He added: 'We miss Yusuf every single day'. Health Secretary Wes Streeting said: 'There are no excuses for the tragic failings in the lead-up to Yusuf's death and I know first-hand how hard it has been for his family to live without the answers they deserve. 'This independent report reveals their concerns were repeatedly not addressed across NHS services. 'It is now the responsibility of the NHS to implement the recommendations in this report so that the family can at least take small comfort in knowing that because of Yusuf, and thanks to Yusuf, children will be safer and better cared for in the future, but I know that really is of no consolation for a loving family living with the unimaginable pain of losing a lovely little boy in these awful circumstances.' Professor Aidan Fowler, national director of patient safety in England, said: 'Our thoughts and sincere condolences remain with the family of Yusuf Nazir who have suffered an unbearable loss. 'We accept the report's recommendations and acknowledge the issues this independent investigation has uncovered, particularly the failure to listen to and act on the concerns of Yusuf's family by multiple NHS services, which is unacceptable.' Dr Jeff Perring, executive medical director at Sheffield Children's NHS Foundation Trust, said: 'The report identifies important areas for learning and improvement, not only for us at Sheffield Children's but also across the wider healthcare system. 'We are dedicated to delivering the improvements outlined in the report's recommendations.' Dr Jo Beahan, medical director at Rotherham NHS Foundation Trust, said: 'Our deepest sympathies remain with Yusuf's family following such a sad loss of a loved family member. We fully co-operated with this investigation into Yusuf's care. 'We have taken steps to address the recommendation and also the concerns raised by Yusuf's family. Our thoughts continue to be with Yusuf's family.'
BBC News
4 minutes ago
- BBC News
Surrey and Sussex NHS Trust receives £12.7m for two new theatres
The Surrey and Sussex NHS Trust has received a funding boost of £12.7m, which they say will allow them to build two new theatres on the site of the East Surrey trust said the funding had arrived at a "crucial time" as current operating theatres on the site were at maximum capacity, as well as growing waiting lists and increasing emergency demand.A spokesperson for the trust said the funding and theatres would mean the hospital could "continue to deliver the highest standards of patient care".The work is due to start on the site in Redhill later in 2025. The trust's chief executive, Angela Stevenson, said: "This new funding from NHS England will be truly transformative for the future of our hospital and our patients. "In the midst of some tough financial decisions, this is a really positive step-change in how we deliver for our patients."
Daily Mail
5 minutes ago
- Daily Mail
Top GP urges men to know the signs of penis cancer... as it becomes a bigger killer than testicular cancer
A leading GP has warned men to watch out for the silent signs of a deadly cancer that kills hundreds each year, overtaking testicular cancer deaths. Penile cancer is notoriously hard to spot because symptoms can easily be mistaken for less serious problems, which men are often too embarrassed to talk about. As a result, late diagnosis is becoming increasingly common, with many men ignoring early warning signs—which could result in amputation. Of men diagnosed with penile cancer early, more than 90 per cent go on to survive at least five years after diagnosis. However, the outlook for men with the most advanced cancer where it has spread to other parts of the body is bleak: no men in this group are expected to survive for five years after their diagnosis. B NHS GP Dr Mark Porter says men could help reduce their risk of a late-stage diagnosis by watching out for the little known signs of the deadly disease which may not only save their lives, but their penises too. According to Cancer Research UK, 63 per cent of penile cancer cases in the UK are preventable. Writing for The Times he said whilst cancer can develop anywhere on the penis, most penile cancers affect the foreskin or the head (glans) of the penis. Common early symptoms include discolouration—which is often red or bluish-brown—a persistent rash or sore that lasts longer than a month, and an obvious lump or growth either on the penis or surrounding groin area. Other red-flag warning signs include bleeding, abnormal discharge and phimosis—where it becomes difficult to retract the foreskin. However, he added these symptoms are not always a cause for serious concern and are usually the result of an infection like thrush or inflammatory conditions. It is also not uncommon for men to experience bleeding after trauma to the sensitive area which can tear the frenulum, the band of tissue that connects the foreskin to the head of the penis. This can happen after intercourse, he added. Even so, Dr Porter urged men not to dismiss any abnormal changes to the area, however slight, and to contact their GP if they are concerned. 'There is a good chance the result won't be as bad as you feared—but that doesn't mean it's okay to put off that appointment,' he said. Whilst penile cancer is rare and typically affects middle-aged men, it can develop much sooner, making early diagnosis crucial. 'The other major advantage of early diagnosis is that often it means treatment is less invasive,' the GP explained. According to the NHS, treatment for early cancer is usually non-surgical, including chemotherapy creams such as 5 fluorouracil and laser therapy through which suspicious lesions are 'burnt off'. However, if the cancer is found later, perhaps as a result of patients putting off seeking help, treatment is a lot more aggressive. This can include removing the top layer of skin from the head of the penis, cutting out lymph nodes—which help the body to fight off infection—and even amputation. A full amputation, known as a penectomy, also involves having to have a new outlet for the bladder made between the anus and scrotum. But, the NHS warns, any surgery is likely to affect how a patient's penis looks. Chemotherapy, radiotherapy and immunotherapy can all also be used to help shrink tumours and reduce the risk of the cancer spreading further. Reconstructive surgery is an option for men who have had to have their penis removed, using skin and muscles from other parts of the body to make a fully functioning penis. Whilst any man can get penile cancer certain factors can increase an individual man's risk of developing the disease. According to the NHS around half of all penile cancers are caused by certain types of HPV which affect the genital area. The virus—medically known as human papillomavirus—can be spread via skin-to-skin contact of the genital area, vaginal, anal or oral sex and sharing sex toys. As such, according to Cancer Research UK, 63 per cent of penile cancer cases are preventable. Smoking also increases the risk of developing the disease and those who are immunocompromised due to conditions like HIV are also more likely to get penile cancer. Dr Porter added: 'Circumcision as a child or teenager offers protection against the disease as it reduced exposure to secretions known as smegma produced by the foreskin.' A six-year study was launched back in 2021 to ascertain how successful a new form of immunotherapy—called cemiplmab—is at treating penile cancer that has spread. The Epic study, led by Professor Amit Bahl a urology professor at the University of Bristol, is still ongoing but if initial findings can be upheld experts believe it could help prolong the lives of men with advanced penile cancer. Around one in 400 men in the UK are diagnosed with penile cancer each year, with the disease killing twice as many men as testicular cancer.
